FIELD: medicine, therapy.
SUBSTANCE: as a sclerotherapeutic preparation one should choose ethoxysclerol to carry out 1-2 courses of therapy at intervals between the courses being 14-21 d. Preparation should be introduced under ultrasound control by introducing 0.5-4%-ethoxysclerol solution at the quantity of 0.5-1 ml/ml nodal volume in case of nodal-type neoplasm. In case of cystic neoplasm - at the quantity of 3-5 ml. Introduction should be fulfilled after liquid aspiration only. One day before the onset of every course of sclerotherapy Movalis 7.5 mg should be prescribed once daily after meals for 5-10 d. The innovation enables to avoid surgical therapy, and, also, increase patients' quality of life due to carrying out sclerosing along with interrupting the pronounced pain syndrome and in some cases heal the disease mentioned.
EFFECT: higher efficiency of therapy.
2 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING BENIGN THYROID NEOPLASMS | 2003 |
|
RU2265435C2 |
METHOD AND PREPARATION FOR TREATING AUTOIMMUNE THYROIDITIS | 2005 |
|
RU2297226C1 |
METHOD OF CHRONIC OPISTHORCHIASISES TREATMENT IN PATIENTS WITH CHRONIC AUTOIMMUNE THYROIDITIS | 2010 |
|
RU2414219C1 |
METHOD OF TREATMENT OF THYROID GLAND DIFFUSE-NODULAR GOITER | 2007 |
|
RU2336895C1 |
METHOD FOR TREATMENT AND PREVENTION OF NODULAR GOITER | 2010 |
|
RU2438678C2 |
METHOD FOR PREDICTING EFFICIENCY IN TREATING THYROID CYSTS DUE TO PERCUTANEOUS ETHANOL SCLEROTHERAPY | 2004 |
|
RU2291430C2 |
METHOD FOR TREATING MAMMARY GLAND CYST | 2000 |
|
RU2185198C2 |
METHOD OF SURGICAL MANAGEMENT OF BENIGN PALPABLE THYROID ABNORMALITIES | 2010 |
|
RU2438604C1 |
METHOD OFFUNCTIONAL OVARY CYST TREATMENT | 2008 |
|
RU2357733C1 |
METHOD OF UNILOCULAR NONPARASITIC SPLEEN CYST SURGERY IN CHILDREN | 2009 |
|
RU2402281C1 |
Authors
Dates
2007-02-27—Published
2005-05-24—Filed